covid

Lilly-partnered AbCellera gets COVID-19 boost from Canadian government

After penning a deal with Eli Lilly last month with the aim to have an antibody in the clinic within four months, Canadian-based AbCellera has been given a financial boost by its government.




covid

Alnylam, Vir plan year-end trial of new RNAi COVID-19 antiviral

Alnylam and Vir Biotechnology have identified an anti-SARS-CoV-2 development candidate, putting them on track to start testing the inhaled RNAi treatment for COVID-19 in humans around the end of the year.




covid

Pfizer, BioNTech dose first U.S. subject with COVID-19 vaccine

Pfizer and BioNTech have begun dosing participants in a U.S. clinical trial of their COVID-19 vaccine candidates. The dose-escalation stage of the trial will enroll up to 360 subjects, initially out of sites in New York and Maryland.




covid

COVID-19: Lilly ramps up to beat the virus with neutralizing antibodies as scientists raise worries

Eli Lilly has teamed with China’s Junshi Biosciences in the U.S., marking the company's second COVID-19 pact to develop neutralizing antibodies against the virus. It promises to be a faster approach than designing a new small-molecule drug would be, but getting from idea to an effective product may not be so simple.




covid

Moderna eyes 'early summer' start for phase 3 COVID-19 vaccine trial

Moderna is finalizing the protocol for a phase 3 trial of its COVID-19 vaccine with a view to starting the study early in the summer. The establishment of the timeline, which follows FDA clearance to run a phase 2 trial, puts Moderna on track to win approval for its mRNA vaccine mRNA-1273 next year.




covid

GSK taps experimental arthritis antibody to calm the cytokine storm hitting COVID-19 patients

GlaxoSmithKline is hard at work with partner Sanofi in getting a vaccine tested for COVID-19, but this morning it said it was now also entering the race to treat patients already hit with the disease.




covid

Sorrento ventures into COVID-19 with Mount Sinai antibody pact

Sorrento Therapeutics is jumping into the race to develop therapies against COVID-19, teaming up with Mount Sinai to develop a cocktail of antibodies from the blood of 15,000 recovered patients. The company's scientists believe their multipronged therapy will sidestep risks such as treatment resistance.




covid

V-E Day: Europe Celebrates A Subdued 75th Anniversary During COVID-19 Pandemic

"Today, 75 years later, we are forced to commemorate alone, but we are not alone!" Germany's President Frank-Walter Steinmeier says, celebrating international unity in the post-war era.




covid

Reopening After COVID: The 3 Phases Recommended By The White House

President Trump wants businesses to start reopening after the coronavirus forced shutdowns. Here's what the White House task force recommends for states.




covid

Do HCP’s want to hear from pharma during COVID-19?



  • in the news
  • Marketing to health care professionals
  • Bad Research

covid

The MDR and the Covid-19 recommendation – a possible template for fixing the MDR and IVDR bottleneck

What is this recommendation about? Obviously this recommendation is an attempt of the Commission to manage administative barriers to placing PPE (personal protective equipment) and medical devices on the market that would be needed in the struggle to get the current Covid-19 pandemic under control. In my view you can also see this as a […]




covid

New MDCG guidance on temporary extraordinary measures related to medical device Notified Body audits during COVID-19 quarantine orders and travel restrictions

When it rains guidance, it pours. The MDCG just released Guidance on temporary extraordinary measures related to medical devices Notified Body audits during COVID-19 quarantine orders and travel restrictions. The guidance takes immediate effect and is valid for the whole period of duration of the pandemic COVID-19 as declared by the World Health Organisation. It […]




covid

COVID-19 cases higher among San Diego's Latinos; advocates call for more testing

In several states and in parts of California, black and Latino people are dying of COVID-19 at higher rates than their white and Asian counterparts.




covid

Opinion: Remdesivir helps beat COVID-19. But the search for a better drug goes on

The drug helped some coronavirus patients recover faster. But it's hardly everything we'd wished for.




covid

All 10 family members in this house got COVID-19. Their patriarch didn't survive

The Ramirezes never thought the coronavirus would get them. They took every precaution, but the virus still found its way into their home. Over the course of days, each member of the 10-person household became infected. Three were hospitalized. And one, the family patriarch, died.




covid

Who to tip and how much for doorstep deliveries during the COVID-19 pandemic

From cash and snacks to a verbal 'thank you,' there are options when it comes to showing your appreciation for delivery drivers.




covid

What COVID-19 patients young and old can teach us about the coronavirus

COVID-19 victims in their 20s and 30s make headlines, but does it mean the coronavirus has become more dangerous to younger people? Here's what we know.




covid

'Chinese virus' and other COVID-19 racism have designers, stylists of Asian heritage pushing back

Enough is enough, says a growing number of creatives from the fashion industry, including designer Kimora Lee Simmons, stylist Jeanne Yang and designer Prabal Gurung.




covid

Swift Enforcement Against COVID Fraudsters

By Anne K. Walsh & Charles D. Snow* —



  • Advertising and Promotion (Federal Trade Commission)
  • Advertising and Promotion (OPDP)
  • COVID19
  • Enforcement

covid

Israeli COVID-19 Vaccine Developments Webinar – Wednesday, May 6, 2020




covid

First child death from mysterious COVID-19-related illness is reported in the U.S

Nearly 100 children in the U.S. have been diagnosed with the newly identified syndrome associated with COVID-19.




covid

India and Pakistan's 'red zones' keep COVID-19 trajectory on rise




covid

Traditional Chinese cures battle for acceptance in COVID-19 fight




covid

India's unemployment at record high amid tough COVID-19 lockdown




covid

UK Prime Minister Boris Johnson tests positive for COVID-19

UK Prime Minister Boris Johnson tested positive for COVID-19 on March 27, 2020.




covid

RBI Measures to counter COVID-19 impact: Repo, CRR Cut, Banks, NBFC's to offer 3 month Moratorium on Loans

The repo rate has been reduced by 75 basis points from 5.15 percent to 4.4 percent.




covid

COVID-19: WHO launches Global Mega Trial with 4 promising drugs

The Global Mega Trial by WHO named Solidarity will include the study and testing of 4 promising drugs in order to develop an antidote of Coronavirus.




covid

Explained: RBI’s Regulatory Package on COVID-19 Decoded: Loan Moratorium to Liquidity Injection

RBI's COVID-19 Regulatory Package: From Repo Rate & CRR Cuts to 3-months moratorium on term loans, RBI Governor Shaktikanta Das announced several measures while addressing the media after the release of Seventh Bi-monthly Monetary Policy Statement 2019-20.




covid

The multifaceted long-term effects of the COVID-19 pandemic on urology





covid

Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study




covid

Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo




covid

Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M<sup>pro</sup>




covid

NKG2A and COVID-19: another brick in the wall




covid

Coronavirus in context: Scite.ai tracks positive and negative citations for COVID-19 literature




covid

Effect of non-pharmaceutical interventions to contain COVID-19 in China




covid

COVID-19 mental-health responses neglect social realities




covid

Let COVID-19 expand awareness of disability tech




covid

COVID-19 assistance needs to target energy insecurity




covid

100 years of influenza research seen through the lens of Covid-19




covid

COVID-19 outcomes in patients with hematologic disease




covid

COVID-19, HCT and wine




covid

Author Correction: Management of IBD during the COVID-19 outbreak: resetting clinical priorities




covid

Obesity and impaired metabolic health in patients with COVID-19




covid

Nanoscale nights of COVID-19




covid

Impact of COVID-19 outbreak on spinal pathology: single center first impression




covid

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing




covid

Changing trends of ocular trauma in the time of COVID-19 pandemic




covid

Surgeon’s protection during ophthalmic surgery in the Covid-19 era: a novel fitted drape for ophthalmic operating microscopes




covid

Impact of the COVID-19 lockdown on basic science research in ophthalmology: the experience of a highly specialized research facility in France